Increasing the uptake of bowel cancer screening in BME communities in Nottingham city: evidence from the literature

Tools

Sandhu, J., Gibson, L. ORCID: 0000-0002-1220-8680 and Pandya-Wood, J. ORCID: 0000-0002-1193-0938, 2015. Increasing the uptake of bowel cancer screening in BME communities in Nottingham city: evidence from the literature. Nottingham: Nottingham City NHS Clinical Commissioning Group.

Preview

Text
13483_Pandya-Wood.pdf - Published version
Download (481kB) | Preview

Abstract

In the UK in 2011, there were 15,659 bowel cancer deaths recorded: 7,139 women and 8,520 men (Cancer Research UK, 2014). In women it is the second most common cancer after breast cancer; for men, it is the third most common after prostate and lung cancers. Between 2009 and 2011, an average of 57 per cent of these bowel cancer deaths occurred in people aged 75 and over (ibid).

Bowel cancer is a predominantly curable disease, especially when it is caught in its early stages (Beating Bowel Cancer, 2012). The mortality rates of bowel cancer have been falling in the UK over the past few decades: the mortality rate for women more than halved over a period of 40 years, falling from 26 deaths per 100,000 people in 1971 to 12.6 deaths in 2011. The rate for men has also shown a significant decline, with 33.5 deaths occurring per 100,000 in 1971 falling to 20.3 deaths in 2011 (Cancer Research UK, 2014).

The NHS Bowel Cancer Screening Programme (BCSP) (NHS Bowel Cancer Screening Programme, 2014) is rolling out a nationwide campaign to screen the population aged between 60 and 69 every two years. Screening for bowel cancer is a test designed to be done at home, in an attempt to make the unpleasant nature of the process as agreeable as possible. People are sent a kit in the post that requires them to add faecal samples and then send back for laboratory testing; this is called a faecal occult blood test (FOBt). There are, however, limitations surrounding the engagement of certain community groups in the uptake of screening for the cancer – these groups of people include black and minority ethnic (BME) groups, the socially and economically deprived and, for some campaigns, men and younger people.

In the UK and many other countries globally, there are initiatives and campaigns to help raise awareness of bowel cancer screening in the community; these are run both in collaboration with governments and by charities and advocacy groups. Work has been done surrounding the identification of barriers faced by individuals and has tried to address ways to breakdown these obstacles and encourage more people to take part in the possible life-saving process. This review will consider some approaches taken by charities and advocacy groups, as well as NHS pilots and examples to consider from other countries.

Item Type:	Research report for external body
Description:	The study was undertaken with c3 Collaborating for Health.
Creators:	Sandhu, J., Gibson, L. and Pandya-Wood, J.
Corporate Creators:	c3 Collaborating for Health
Publisher:	Nottingham City NHS Clinical Commissioning Group
Place of Publication:	Nottingham
Date:	2015
Divisions:	Schools > School of Social Sciences
Record created by:	Jonathan Gallacher
Date Added:	18 Mar 2019 09:55
Last Modified:	18 Mar 2019 09:55
URI:	https://irep.ntu.ac.uk/id/eprint/36054